Danaher outlines 2026 growth target of 3%-6% amid cost actions and bioprocessing momentum
Earnings Call Insights: Danaher Corporation (DHR) Q3 2025 CEO Rainer Blair emphasized strong third quarter results, driven...
Tag: DHR
Danaher rises as Diagnostics unit powers Q3 beat
Danaher (NYSE:DHR) added ~8% in the premarket on Tuesday as the U.S. life sciences company reported its Q3 2025 financials,...
Danaher beats top-line and bottom-line estimates; reaffirms FY25 outlook
Danaher press release (NYSE:DHR): Q3 Non-GAAP EPS of $1.89 beats by $0.17. Revenue of $6.05B (+4.3% Y/Y) beats by $50M....
Danaher Q3 2025 Earnings Preview
Danaher (NYSE:DHR) is scheduled to announce Q3 earnings results on Tuesday, October 21st, before market open. The consensus...
Danaher declares $0.32 dividend
Danaher (NYSE:DHR) declares $0.32/share quarterly dividend, in line with previous. Forward yield 0.66% Payable Oct. 31; for...
Danaher raises full-year EPS guidance to $7.70-$7.80 amid robust bioprocessing growth and portfolio resilience
Earnings Call Insights: Danaher Corporation (DHR) Q2 2025 Rainer M. Blair, President and CEO, announced a CFO succession...
Danaher slips despite Q2 beat as Life Sciences unit underperforms
Zerbor/iStock via Getty ImagesDanaher Corporation (NYSE:DHR) traded ~4% lower in the premarket on Tuesday after the...
Danaher names new finance chief
Danaher (NYSE:DHR) said that Matthew Gugino, the current group CFO of the company's Life Sciences Innovations Group and VP...
Earnings Snapshot: Danaher surpasses Q2 estimates; raises FY25 Adj. EPS outlook
Seeking Alpha (Seeking Alpha) *Other Operating Data Consensus Source: Bloomberg Danaher: Biotech Momentum, Cost Cuts And...
Danaher Non-GAAP EPS of $1.80 beats by $0.16, revenue of $5.9B beats by $60M
Danaher press release (NYSE:DHR): Q2 Non-GAAP EPS of $1.80 beats by $0.16. Revenue of $5.9B (+3.5% Y/Y) beats by $60M....